Selvita S.A. (GPW: SLV) Stock Analysis & Fundamentals | ScreenerHero

Create free account

SLVSelvita S.A.

GPW · PL · Healthcare · Diagnostics & Research · selvita.com

31.40PLN+0.48%Mkt Cap: 145.94M $P/E: —1d ago

Selvita S.A. provides drug discovery, drug development, and contract testing services in Poland. The company offers computer-aided drug design and artificial intelligence solutions, including structure-based drug design,…

Industry Peers

Diagnostics & Research

vs Diagnostics & Research

P/B

Cheaper

1M Perf

Avg

Thermo Fisher Scientific Inc.

$194.52BUSDP/E 28.7

Danaher Corporation

$140.09BUSDP/E 38.3

$45.77BUSDP/E 44.2

IDEXX Laboratories, Inc.

$44.00BUSDP/E 41.0

Waters Corporation

$37.24BUSDP/E 48.3

Agilent Technologies, Inc.

$36.91BUSDP/E 26.2

IQVIA Holdings Inc.

$34.55BUSDP/E 25.7

$28.55BUSDP/E 34.4

Mettler-Toledo International Inc.

$26.44BUSDP/E 30.8

Quest Diagnostics Incorporated

$23.88BUSDP/E 23.8

Labcorp Holdings Inc.

$23.53BUSDP/E 25.4

Guardant Health, Inc.

Medpace Holdings, Inc.

$15.92BUSDP/E 35.1

Eurofins Scientific SE

$13.05BUSDP/E 27.2

$12.69BUSDP/E 54.7

Charles River Laboratories International, Inc.

bioMérieux S.A.

$8.90BUSDP/E 20.8

Twist Bioscience Corporation

BillionToOne, Inc.

$5.54BUSDP/E 222.9

Sotera Health Company

$5.11BUSDP/E 43.7

$4.55BUSDP/E 52.9

DiaSorin S.p.A.

$3.76BUSDP/E 26.4

Adaptive Biotechnologies Corporation

GeneDx Holdings Corp.

NeoGenomics, Inc.

Vimian Group AB (publ)

$1.53BUSDP/E 38.8

Diagnostyka S.A.

$1.55BUSDP/E 23.4

Personalis, Inc.

OPKO Health, Inc.

Clínica Baviera, S.A.

$1.03BUSDP/E 21.7

Castle Biosciences, Inc.

$616.40MUSDP/E 40.2

Fulgent Genetics, Inc.

Myriad Genetics, Inc.

$305.89MUSDP/E 3.1

Spectral Medical Inc.

Insight Molecular Diagnostics Inc.

Eurofins-Cerep SA

$94.30MUSDP/E 18.1

Pangaea Oncology, S.A.

Abingdon Health Plc

Immunovia AB (publ)

$10.08MUSDP/E 63.3

Proteome Sciences plc

ENDRA Life Sciences Inc.

Oxford BioDynamics Plc

bioAffinity Technologies, Inc.

Avricore Health Inc.

Leveljump Healthcare Corp.

$3.86MUSDP/E 2.8

Telo Genomics Corp.

Prostatype Genomics AB (publ)

ProPhase Labs, Inc.

Many Bright Ideas Technologies Inc.

$314.2KUSDP/E Infinity

T2 Biosystems, Inc.

Indicators:|

Key Statistics

Company

Market Cap145.94M $

Enterprise Value185.32M $

Revenue (TTM)91.16M $

Gross Profit74.30M $

Net Income (TTM)205.90K $

Revenue/Share4.966 USD

Last Price31.40 PLN

Fiscal Year EndDec 2025

MR QuarterMar 2026

Employees691

CountryPL

SectorHealthcare

IndustryDiagnostics & Research

ISIN—

Valuation

P/E (Trailing)—

P/E (Forward)19.81

PEG—

EV/EBITDA11.12

EV/Revenue2.03

P/S1.62

P/B1.84

EPS (TTM)-0.21

EPS (Forward)—

52W Range

28.1015% of range49.40

52W High49.40 PLN

52W Low28.10 PLN

Profitability

Gross Margin80.55%

Oper. Margin-2.23%

EBITDA Margin18.28%

Profit Margin0.22%

ROE0.25%

ROA0.14%

Growth

Revenue Growth-12.30%

Earnings Growth—

Cash Flow & Leverage

Operating CF18.55M $

CapEx (TTM)1.81M $

FCF Margin16.60%

FCF Yield10.37%

Net Debt37.49M $

Net Debt/EBITDA2.25

Balance Sheet

Debt/Equity0.53

Current Ratio1.00

Quick Ratio0.87

Book Value/Sh17.27 PLN

Cash/Share1.084 PLN

Dividends

Fwd Div Rate—

Trail. Div Rate0.0000 PLN

Div. Yield—

5Y Avg Yield—

Payout Ratio0.00%

Ex-Div Date—

Pay Date—

Analyst Consensus

Rating—

Target (Mean)47.32 PLN

Upside (mean)+50.7%

Target Range31.00 PLN – 65.30 PLN

PLN31.00+50.7% to meanPLN65.30

# Analysts6

Ownership

Shares Out.18.35M

Float9.71M

Insiders21.18%

Institutions23.38%

Technical

SMA 5031.88 (-1.5%)

SMA 20038.14 (-17.7%)

Beta0.04

S&P 52W Chg20.05%

Avg Vol (30d)25.07K

Avg Vol (10d)8.32K

Technical Indicators

RSI (14)51.9

MACD-0.0079

MACD Signal-0.2024

MACD Hist.+0.1945

BB Upper32.31 PLN

BB Middle30.79 PLN

BB Lower29.27 PLN

BB Width9.89%

ATR (14)1.120 PLN

Vol Ratio (20d)0.37x